Matthew J. Wolf, Dagny Noeth, C. Rammohan, Svati H. Shah
{"title":"Complexities of Genetic Testing in Familial Dilated Cardiomyopathy","authors":"Matthew J. Wolf, Dagny Noeth, C. Rammohan, Svati H. Shah","doi":"10.1161/CIRCGENETICS.115.001157","DOIUrl":null,"url":null,"abstract":"A 59-year-old female with a personal and family history of dilated cardiomyopathy (DCM) was referred by her cardiologist for genetic testing and counseling. The patient was initially diagnosed with DCM after presenting with dyspnea and fatigue. Her symptoms also included mild bilateral pedal edema, but she denied orthopnea, paroxysmal nocturnal dyspnea, palpitations, presyncope, or syncope. An electrocardiogram showed sinus rhythm and a left bundle branch block morphology (Figure 1). She underwent a gadolinium-enhanced cardiac magnetic resonance imaging that showed an enlarged left ventricle (LV; internal diameter at end diastole and systole were 6.5 cm and 5.4 cm, respectively), and the LV ejection fraction was ≈25%. Abnormal septal wall motion consistent with a bundle branch block was noted. All other walls of the LV were diffusely hypokinetic. Mild midmyocardial hyperenhancement suggestive of idiopathic DCM was present. The right ventricle was normal in size and function. There were no valvular abnormalities. Left heart catheterization showed no significant epicardial coronary artery disease. She was treated with a β-adrenergic antagonist, an angiotensinogen inhibitor, a mineralocorticoid antagonist, and a loop diuretic. Her symptoms improved; however, the LV remained enlarged and had poor systolic function with an ejection fraction of ≈30%. She subsequently underwent biventricular implantable cardioverter-defibrillator implantation.\n\n\n\nFigure 1. \nECG of proband. Heart rate (HR) in bpm, P–R interval (PR) in milliseconds (ms), QRS duration (QRS) in ms, Q–T interval (QT) in ms, and corrected Q–T interval using Bazett formula (QTc) in ms are shown. aVF indicates augmented vector foot; aVL, augmented vector left; and aVR, augmented vector right.\n\n\n\nAt the time of her initial diagnosis, the patient’s family history was notable for a 86-year-old mother who had atrial fibrillation and valvular heart disease; a father who died at the age of 89 years with coronary artery disease; a 59-year-old sister who had hypertension; a 50-year-old brother …","PeriodicalId":48940,"journal":{"name":"Circulation-Cardiovascular Genetics","volume":"9 1","pages":"95–99"},"PeriodicalIF":0.0000,"publicationDate":"2016-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1161/CIRCGENETICS.115.001157","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation-Cardiovascular Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/CIRCGENETICS.115.001157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 5
Abstract
A 59-year-old female with a personal and family history of dilated cardiomyopathy (DCM) was referred by her cardiologist for genetic testing and counseling. The patient was initially diagnosed with DCM after presenting with dyspnea and fatigue. Her symptoms also included mild bilateral pedal edema, but she denied orthopnea, paroxysmal nocturnal dyspnea, palpitations, presyncope, or syncope. An electrocardiogram showed sinus rhythm and a left bundle branch block morphology (Figure 1). She underwent a gadolinium-enhanced cardiac magnetic resonance imaging that showed an enlarged left ventricle (LV; internal diameter at end diastole and systole were 6.5 cm and 5.4 cm, respectively), and the LV ejection fraction was ≈25%. Abnormal septal wall motion consistent with a bundle branch block was noted. All other walls of the LV were diffusely hypokinetic. Mild midmyocardial hyperenhancement suggestive of idiopathic DCM was present. The right ventricle was normal in size and function. There were no valvular abnormalities. Left heart catheterization showed no significant epicardial coronary artery disease. She was treated with a β-adrenergic antagonist, an angiotensinogen inhibitor, a mineralocorticoid antagonist, and a loop diuretic. Her symptoms improved; however, the LV remained enlarged and had poor systolic function with an ejection fraction of ≈30%. She subsequently underwent biventricular implantable cardioverter-defibrillator implantation.
Figure 1.
ECG of proband. Heart rate (HR) in bpm, P–R interval (PR) in milliseconds (ms), QRS duration (QRS) in ms, Q–T interval (QT) in ms, and corrected Q–T interval using Bazett formula (QTc) in ms are shown. aVF indicates augmented vector foot; aVL, augmented vector left; and aVR, augmented vector right.
At the time of her initial diagnosis, the patient’s family history was notable for a 86-year-old mother who had atrial fibrillation and valvular heart disease; a father who died at the age of 89 years with coronary artery disease; a 59-year-old sister who had hypertension; a 50-year-old brother …
期刊介绍:
Circulation: Genomic and Precision Medicine considers all types of original research articles, including studies conducted in human subjects, laboratory animals, in vitro, and in silico. Articles may include investigations of: clinical genetics as applied to the diagnosis and management of monogenic or oligogenic cardiovascular disorders; the molecular basis of complex cardiovascular disorders, including genome-wide association studies, exome and genome sequencing-based association studies, coding variant association studies, genetic linkage studies, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics; integration of electronic health record data or patient-generated data with any of the aforementioned approaches, including phenome-wide association studies, or with environmental or lifestyle factors; pharmacogenomics; regulation of gene expression; gene therapy and therapeutic genomic editing; systems biology approaches to the diagnosis and management of cardiovascular disorders; novel methods to perform any of the aforementioned studies; and novel applications of precision medicine. Above all, we seek studies with relevance to human cardiovascular biology and disease. Manuscripts are examined by the editorial staff and usually evaluated by expert reviewers assigned by the editors. Both clinical and basic articles will also be subject to statistical review, when appropriate. Provisional or final acceptance is based on originality, scientific content, and topical balance of the journal. Decisions are communicated by email, generally within six weeks. The editors will not discuss a decision about a manuscript over the phone. All rebuttals must be submitted in writing to the editorial office.